Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
28.70
+0.06 (0.21%)
Jun 4, 2025, 1:18 PM - Market open
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $1.91 billion as of June 4, 2025. Its market cap has decreased by -1.97% in one year.
Market Cap
1.91B
Enterprise Value
-1.83B
1-Year Change
-1.97%
Ranking
Category
Stock Price
$28.70
Market Cap Chart
Since May 14, 2015, Galapagos NV's market cap has increased from $1.86B to $1.91B, an increase of 2.45%. That is a compound annual growth rate of 0.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2025 | 1.89B | 4.14% |
| Dec 31, 2024 | 1.81B | -32.28% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.93B |
| Johnson & Johnson | 368.83B |
| AbbVie | 327.37B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 283.02B |
| Abbott Laboratories | 230.95B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |